CN118772066A - A slightly acidic environment responsive AIE fluorescent probe and its preparation method and application - Google Patents
A slightly acidic environment responsive AIE fluorescent probe and its preparation method and application Download PDFInfo
- Publication number
- CN118772066A CN118772066A CN202410850451.8A CN202410850451A CN118772066A CN 118772066 A CN118772066 A CN 118772066A CN 202410850451 A CN202410850451 A CN 202410850451A CN 118772066 A CN118772066 A CN 118772066A
- Authority
- CN
- China
- Prior art keywords
- solution
- fluorescent probe
- tpe
- aie
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 104
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 230000002378 acidificating effect Effects 0.000 title claims description 39
- 239000000243 solution Substances 0.000 claims abstract description 115
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims abstract description 54
- 239000002904 solvent Substances 0.000 claims abstract description 54
- 239000011259 mixed solution Substances 0.000 claims abstract description 32
- 229940124530 sulfonamide Drugs 0.000 claims abstract description 20
- 238000003756 stirring Methods 0.000 claims abstract description 19
- -1 sulfonamide compounds Chemical class 0.000 claims abstract description 18
- 229960004673 sulfadoxine Drugs 0.000 claims abstract description 16
- 210000004881 tumor cell Anatomy 0.000 claims abstract description 16
- PJSFRIWCGOHTNF-UHFFFAOYSA-N Sulphormetoxin Chemical compound COC1=NC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1OC PJSFRIWCGOHTNF-UHFFFAOYSA-N 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 239000005457 ice water Substances 0.000 claims abstract description 14
- 239000007787 solid Substances 0.000 claims abstract description 13
- 150000001263 acyl chlorides Chemical class 0.000 claims abstract description 12
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 claims abstract description 6
- SKIVFJLNDNKQPD-UHFFFAOYSA-N sulfacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 SKIVFJLNDNKQPD-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960002673 sulfacetamide Drugs 0.000 claims abstract description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 44
- 150000003384 small molecules Chemical class 0.000 claims description 34
- 238000006243 chemical reaction Methods 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- MPYOMTPWHUPLKU-UHFFFAOYSA-N 4-[1,2,2-tris(4-carboxyphenyl)ethenyl]benzoic acid Chemical group C1=CC(C(=O)O)=CC=C1C(C=1C=CC(=CC=1)C(O)=O)=C(C=1C=CC(=CC=1)C(O)=O)C1=CC=C(C(O)=O)C=C1 MPYOMTPWHUPLKU-UHFFFAOYSA-N 0.000 claims description 22
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 22
- 238000003384 imaging method Methods 0.000 claims description 17
- 238000010992 reflux Methods 0.000 claims description 14
- 238000010898 silica gel chromatography Methods 0.000 claims description 14
- 238000001704 evaporation Methods 0.000 claims description 13
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical group ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 14
- 239000000203 mixture Substances 0.000 abstract description 14
- 230000004044 response Effects 0.000 abstract description 13
- 239000000523 sample Substances 0.000 abstract description 9
- 239000002253 acid Substances 0.000 abstract description 4
- 238000007112 amidation reaction Methods 0.000 abstract description 4
- 238000001035 drying Methods 0.000 abstract description 3
- 238000012632 fluorescent imaging Methods 0.000 abstract description 2
- 238000000935 solvent evaporation Methods 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 90
- 210000004027 cell Anatomy 0.000 description 50
- 206010028980 Neoplasm Diseases 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- 239000010413 mother solution Substances 0.000 description 20
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 19
- 239000011973 solid acid Substances 0.000 description 18
- 238000001514 detection method Methods 0.000 description 15
- 239000001963 growth medium Substances 0.000 description 14
- 230000007704 transition Effects 0.000 description 14
- 238000000799 fluorescence microscopy Methods 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 230000002776 aggregation Effects 0.000 description 11
- 238000004220 aggregation Methods 0.000 description 11
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 10
- 239000007853 buffer solution Substances 0.000 description 9
- 239000000872 buffer Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- JLZUZNKTTIRERF-UHFFFAOYSA-N tetraphenylethylene Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)=C(C=1C=CC=CC=1)C1=CC=CC=C1 JLZUZNKTTIRERF-UHFFFAOYSA-N 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 231100000135 cytotoxicity Toxicity 0.000 description 6
- 230000003013 cytotoxicity Effects 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 230000005284 excitation Effects 0.000 description 6
- 238000002189 fluorescence spectrum Methods 0.000 description 6
- 238000004020 luminiscence type Methods 0.000 description 6
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 235000019439 ethyl acetate Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 210000003712 lysosome Anatomy 0.000 description 4
- 230000001868 lysosomic effect Effects 0.000 description 4
- 230000005588 protonation Effects 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 230000000171 quenching effect Effects 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000006174 pH buffer Substances 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 239000002096 quantum dot Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 125000000565 sulfonamide group Chemical group 0.000 description 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 2
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 2
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 230000004700 cellular uptake Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000005595 deprotonation Effects 0.000 description 2
- 238000010537 deprotonation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000005281 excited state Effects 0.000 description 2
- 238000002073 fluorescence micrograph Methods 0.000 description 2
- 102000034287 fluorescent proteins Human genes 0.000 description 2
- 108091006047 fluorescent proteins Proteins 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000006862 quantum yield reaction Methods 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- NBWRJAOOMGASJP-UHFFFAOYSA-N 2-(3,5-diphenyl-1h-tetrazol-1-ium-2-yl)-4,5-dimethyl-1,3-thiazole;bromide Chemical compound [Br-].S1C(C)=C(C)N=C1N1N(C=2C=CC=CC=2)N=C(C=2C=CC=CC=2)[NH2+]1 NBWRJAOOMGASJP-UHFFFAOYSA-N 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- QZPSXPBJTPJTSZ-UHFFFAOYSA-N aqua regia Chemical compound Cl.O[N+]([O-])=O QZPSXPBJTPJTSZ-UHFFFAOYSA-N 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 238000001815 biotherapy Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- MHKKFFHWMKEBDW-UHFFFAOYSA-N dimethyl 2,5-dioxocyclohexane-1,4-dicarboxylate Chemical compound COC(=O)C1CC(=O)C(C(=O)OC)CC1=O MHKKFFHWMKEBDW-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000035440 response to pH Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 description 1
- 229960000973 sulfadimethoxine Drugs 0.000 description 1
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 description 1
- 229960001544 sulfathiazole Drugs 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/50—Nitrogen atoms bound to hetero atoms
- C07D277/52—Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1037—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Materials Engineering (AREA)
- Biomedical Technology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
技术领域Technical Field
本发明属于荧光探针技术领域,具体涉及一种微酸环境响应AIE荧光探针及其制备方法和应用。The present invention belongs to the technical field of fluorescent probes, and in particular relates to a slightly acidic environment responsive AIE fluorescent probe and a preparation method and application thereof.
背景技术Background Art
生物成像是生物医学研究中的一个强有力的工具,在疾病的早期诊断和治疗以及基础药物的开发中具有重要意义。生物成像技术包括磁共振成像、X射线计算机层析成像、荧光成像、放射性核素成像和光声断层扫描等。荧光成像具有操作简单、响应速度快和高选择性等优点,已经成为不可或缺的生物成像工具。在过去的几十年里,各种光学试剂如荧光蛋白、量子点(QDs)、常规有机染料广泛应用于荧光成像领域。但存在着一些问题,例如量子点中存在重金属离子可能会造成一定的细胞毒性,以及复杂而耗时的荧光蛋白转染程序。Bioimaging is a powerful tool in biomedical research and is of great significance in the early diagnosis and treatment of diseases and the development of basic drugs. Bioimaging techniques include magnetic resonance imaging, X-ray computed tomography, fluorescence imaging, radionuclide imaging, and photoacoustic tomography. Fluorescence imaging has the advantages of simple operation, fast response speed, and high selectivity, and has become an indispensable bioimaging tool. In the past few decades, various optical reagents such as fluorescent proteins, quantum dots (QDs), and conventional organic dyes have been widely used in the field of fluorescence imaging. However, there are some problems, such as the presence of heavy metal ions in quantum dots that may cause certain cytotoxicity, and the complicated and time-consuming fluorescent protein transfection procedure.
有机荧光材料因具有价格低廉、毒性小、操作简单、结构易调、高信噪比、光稳定性好、优异的荧光量子产率、更深的组织穿透力和更高的空间分辨率等优点,在光电子器件、检测、生物成像和生物治疗等领域具有良好的应用前景,已成为微观生物学和病理学研究的强大工具。然而,传统的有机荧光分子大多具有平面共轭结构,在聚集态时容易发生π-π堆积,在激发态时能量损失严重导致发光性能较差,会出现聚集诱导猝灭(ACQ)问题。尽管许多类型的荧光团已经商业化应用在生物成像方面,由于其光稳定性较差、聚集引起的猝灭效应(ACQ)以及复杂的荧光团合成阻碍了荧光团进一步发展。Organic fluorescent materials have good application prospects in optoelectronic devices, detection, bioimaging and biotherapy due to their advantages such as low price, low toxicity, simple operation, easy structure adjustment, high signal-to-noise ratio, good photostability, excellent fluorescence quantum yield, deeper tissue penetration and higher spatial resolution. They have become powerful tools for microbiological and pathological research. However, most traditional organic fluorescent molecules have planar conjugated structures, which are prone to π-π stacking in the aggregated state. In the excited state, the energy loss is serious, resulting in poor luminescence performance and aggregation-induced quenching (ACQ) problems. Although many types of fluorophores have been commercially used in bioimaging, their poor photostability, aggregation-induced quenching (ACQ) and complex fluorophore synthesis have hindered their further development.
近年来,具有酸响应的AIE荧光探针为避免ACQ问题提供了有效策略,一种新型的聚集诱导发光(AIE)特性的小分子荧光探针有效地克服了传统荧光染料的缺陷。AIE荧光探针具有众多优势,如在聚集状态下亮度优异、斯托克斯位移偏移大、良好的光稳定性和高信噪比等方面,可以灵敏地响应肿瘤微环境特征用于肿瘤组织成像。将酸性微环境与可电离的化学基团相结合,通过质子化或去质子化响应环境pH变化。但是常用的可电离基团,如羧酸和叔氨基团,在pH 5.0-6.5的范围内进行质子化或去质子化,低于酸性TME的pH(pH≈6.2-6.9),无法应用于肿瘤微环境。荧光探针虽然有一定的优势,但存在响应范围宽、缺乏明确的pH转变点、无法利用肿瘤微酸环境的差异准确区分正常组织和肿瘤组织等问题。In recent years, acid-responsive AIE fluorescent probes have provided an effective strategy to avoid the ACQ problem. A new type of small molecule fluorescent probe with aggregation-induced emission (AIE) characteristics has effectively overcome the defects of traditional fluorescent dyes. AIE fluorescent probes have many advantages, such as excellent brightness in the aggregated state, large Stokes shift offset, good photostability and high signal-to-noise ratio, and can sensitively respond to tumor microenvironment characteristics for tumor tissue imaging. The acidic microenvironment is combined with ionizable chemical groups to respond to environmental pH changes through protonation or deprotonation. However, commonly used ionizable groups, such as carboxylic acids and tertiary amino groups, are protonated or deprotonated in the pH range of 5.0-6.5, which is lower than the pH of the acidic TME (pH≈6.2-6.9) and cannot be applied to the tumor microenvironment. Although fluorescent probes have certain advantages, they have problems such as a wide response range, lack of a clear pH transition point, and inability to accurately distinguish normal tissue from tumor tissue using differences in the slightly acidic environment of the tumor.
现有技术一(CN117586205A)公开了一种靶向溶酶体pH荧光探针及其制备方法和应用,以1,4-环己二酮-2,5-二甲酸二甲酯为骨架,通过与吗啉基团之间的质子化,形成对酸碱敏感的pH荧光探针,该探针可实现固液双高效发光,具有较高的荧光量子产率,随着pH的增加荧光强度逐渐减弱,具有较好的抗干扰能力和抗光漂白性,细胞毒性较低,细胞成像实验证明,该探针能有效的定位于溶酶体中,并能检测溶酶体及斑马鱼内不同pH值的变化。但该pH荧光探针没有明确的pH转变点,虽然可以靶向溶酶体,但无法有效区分正常细胞和肿瘤细胞,应用前景受限。Prior art 1 (CN117586205A) discloses a lysosomal pH fluorescent probe and its preparation method and application, with 1,4-cyclohexanedione-2,5-dicarboxylic acid dimethyl ester as the skeleton, and through protonation with the morpholine group, an acid-base sensitive pH fluorescent probe is formed. The probe can achieve solid-liquid dual-efficiency luminescence, has a high fluorescence quantum yield, and the fluorescence intensity gradually weakens with the increase of pH. It has good anti-interference ability and anti-photobleaching, and low cytotoxicity. Cell imaging experiments have shown that the probe can be effectively located in lysosomes and can detect changes in different pH values in lysosomes and zebrafish. However, the pH fluorescent probe does not have a clear pH transition point. Although it can target lysosomes, it cannot effectively distinguish normal cells from tumor cells, and its application prospects are limited.
现有技术二(CN117777018A)公开了一种双通道检测粘度和pH的荧光探针及其制备方法和应用,在生物细胞体系中粘度和pH选择性动态可视化检测以及制备肿瘤细胞成像检测制剂中的应用。本发明制备的荧光探针具有特异性强、选择性好、光稳定性好、线粒体和溶酶体双靶向能力优异等特点。但该双通道检测粘度和pH的荧光探针合成步骤较为繁琐且条件较为苛刻。Prior art 2 (CN117777018A) discloses a dual-channel fluorescent probe for detecting viscosity and pH, its preparation method and application, and its application in selective dynamic visualization detection of viscosity and pH in biological cell systems and in the preparation of tumor cell imaging detection preparations. The fluorescent probe prepared by the present invention has the characteristics of strong specificity, good selectivity, good photostability, and excellent dual targeting ability of mitochondria and lysosomes. However, the synthesis steps of the dual-channel fluorescent probe for detecting viscosity and pH are relatively cumbersome and the conditions are relatively harsh.
因此结合以上分析,相关现有技术中AIE荧光探针仍然存在如下缺陷有待改进:其一、对AIE分子进行基团修饰后的荧光探针,难以实现在肿瘤酸性部位响应聚集,而是表现出碱性聚集、酸性分散的特点,且在在正常生理环境pH 7.4时其荧光强度较弱且远达不到满足细胞成像需求。其原因是:单一的简便的基团修饰无法有效调控四苯乙烯(TPE)的分子内旋转过程,导致无法获得理想的pH转变点及转变区间。其二、利用近红外激发,超声,蛋白标记等条件开发的荧光探针,虽然能够实现肿瘤细胞成像的过程,但响应范围较宽,且缺乏明确的pH转变点,制备流程较为繁琐,对人体造成不可逆损伤。其原因是:同时引入多种性能使荧光探针的制备过程变得复杂,需借助外界较为强烈的刺激达到活体成像的目的。Therefore, combined with the above analysis, the AIE fluorescent probes in the related prior art still have the following defects to be improved: First, the fluorescent probes after the AIE molecules are modified with groups are difficult to achieve response aggregation in the acidic part of the tumor, but show the characteristics of alkaline aggregation and acidic dispersion, and the fluorescence intensity is weak at pH 7.4 in the normal physiological environment and far from meeting the needs of cell imaging. The reason is: a single simple group modification cannot effectively regulate the intramolecular rotation process of tetraphenylethylene (TPE), resulting in the inability to obtain the ideal pH transition point and transition interval. Second, the fluorescent probes developed using near-infrared excitation, ultrasound, protein labeling and other conditions can achieve the process of tumor cell imaging, but the response range is wide, and there is a lack of a clear pH transition point. The preparation process is relatively cumbersome and causes irreversible damage to the human body. The reason is: the introduction of multiple properties at the same time makes the preparation process of the fluorescent probe complicated, and it is necessary to use a relatively strong external stimulus to achieve the purpose of in vivo imaging.
因此,针对现有相关技术中荧光成像技术信噪比低、细胞毒性高和聚集诱导猝灭现象等不足,需要研发一种响应于肿瘤酸性微环境的AIE荧光探针,从而解决肿瘤部位成像灵敏度低等难题,以实现pH响应的荧光成像效果,为靶向肿瘤酸性微环境提供一种有效方法。Therefore, in view of the shortcomings of existing fluorescence imaging technologies such as low signal-to-noise ratio, high cytotoxicity and aggregation-induced quenching, it is necessary to develop an AIE fluorescent probe that responds to the acidic microenvironment of the tumor, so as to solve the problem of low imaging sensitivity in the tumor site, so as to achieve pH-responsive fluorescence imaging effect and provide an effective method for targeting the acidic microenvironment of the tumor.
发明内容Summary of the invention
为至少解决上述问题之一,本发明提供一种微酸环境响应AIE荧光探针及其制备方法和应用。本方案所制备的小分子荧光探针通过微酸pH响应基团设计,提升其在肿瘤成像中的检测灵敏度。当荧光探针到达肿瘤部位时,在肿瘤微酸环境中,导致酰胺键质子化,整体呈电中性。聚集状态下在细胞内发出明亮荧光,实现对肿瘤细胞安全有效的选择性荧光成像。In order to solve at least one of the above problems, the present invention provides a slightly acidic environment responsive AIE fluorescent probe and its preparation method and application. The small molecule fluorescent probe prepared in this scheme is designed with a slightly acidic pH responsive group to improve its detection sensitivity in tumor imaging. When the fluorescent probe reaches the tumor site, in the slightly acidic environment of the tumor, the amide bond is protonated and the whole is electrically neutral. In the aggregated state, bright fluorescence is emitted in the cell, realizing safe and effective selective fluorescence imaging of tumor cells.
本发明的目的之一是提供一种微酸环境响应AIE荧光探针,其结构通式为:One of the purposes of the present invention is to provide a slightly acidic environment responsive AIE fluorescent probe, the general structural formula of which is:
其中,R选自 中的一种。Among them, R is selected from One of them.
作为优选方案,所述荧光探针的结构式为:As a preferred embodiment, the structural formula of the fluorescent probe is:
本发明的目的之二是提供一种微酸环境响应AIE荧光探针的制备方法,包括如下步骤:The second object of the present invention is to provide a method for preparing a slightly acidic environment responsive AIE fluorescent probe, comprising the following steps:
步骤一、将磺胺类化合物溶于一定量的溶剂中,并按照比例加入三乙胺,置于冰水浴搅拌10-30min,得到第一溶液;Step 1, dissolving the sulfonamide compound in a certain amount of solvent, adding triethylamine according to a proportion, placing in an ice water bath and stirring for 10-30 minutes to obtain a first solution;
步骤二、将一定量的酰氯固体溶于一定量的溶剂中得到第二溶液,并将第二溶液滴加至步骤一所配制得到的第一溶液中,从而制备混合溶液;Step 2: dissolving a certain amount of acyl chloride solid in a certain amount of solvent to obtain a second solution, and adding the second solution dropwise to the first solution prepared in step 1 to prepare a mixed solution;
步骤三、待第二溶液滴加完毕后,步骤二所制备得到的混合溶液在一定反应温度下搅拌48-72h,并将反应完成的混合溶液蒸发溶剂后的残余物通过纯化干燥得到荧光探针化合物。Step 3: After the second solution is added dropwise, the mixed solution prepared in step 2 is stirred at a certain reaction temperature for 48-72 hours, and the residue after evaporating the solvent of the mixed solution after the reaction is completed is purified and dried to obtain a fluorescent probe compound.
作为优选方案,步骤二中,所述酰氯固体的制备方法如下:将1,1,2,2-四(4-羧基苯)乙烯按照比例溶于二氯亚砜中;并将所得溶液在回流温度下反应24-48h;待反应结束后,将反应液冷却至室温,然后除去溶剂得到固体酰氯。As a preferred embodiment, in step 2, the preparation method of the solid acyl chloride is as follows: dissolving 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene in dichlorothionyl according to a proportion; and reacting the obtained solution at reflux temperature for 24-48 hours; after the reaction is completed, cooling the reaction solution to room temperature, and then removing the solvent to obtain a solid acyl chloride.
作为优选方案,每1g1,1,2,2-四(4-羧基苯)乙烯投加在70-100mL的二氯亚砜中。As a preferred embodiment, 1 g of 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene is added into 70-100 mL of thionyl chloride.
作为优选方案,1,1,2,2-四(4-羧基苯)乙烯:磺胺类化合物:三乙胺的摩尔比范围为1:4-8:8-12,所述磺胺类化合物选自苯磺酰胺、磺胺醋酰或磺胺多辛中的一种;优选的,磺胺类化合物采用磺胺多辛,1,1,2,2-四(4-羧基苯)乙烯:磺胺多辛:三乙胺的摩尔比范围为1:4-8:8-12。As a preferred embodiment, the molar ratio of 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene:sulfonamide compound:triethylamine is in the range of 1:4-8:8-12, and the sulfonamide compound is selected from one of benzenesulfonamide, sulfacetamide or sulfadoxine; preferably, the sulfonamide compound is sulfadoxine, and the molar ratio of 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene:sulfadoxine:triethylamine is in the range of 1:4-8:8-12.
作为优选方案,所述步骤三中,所述反应温度为25-50℃。As a preferred embodiment, in the step three, the reaction temperature is 25-50°C.
作为优选方案,包括如下步骤:As a preferred solution, the following steps are included:
步骤一、将磺胺多辛溶于一定量的四氢呋喃中,并按照比例加入三乙胺,置于冰水浴搅拌10-30min,得到第一溶液;Step 1, dissolving sulfadoxine in a certain amount of tetrahydrofuran, adding triethylamine according to a proportion, placing in an ice water bath and stirring for 10-30 minutes to obtain a first solution;
步骤二、将一定量的酰氯固体溶于一定量的四氢呋喃中得到第二溶液,并将第二溶液滴加至步骤一所配制得到的第一溶液中,从而制备混合溶液;Step 2: dissolving a certain amount of acyl chloride solid in a certain amount of tetrahydrofuran to obtain a second solution, and adding the second solution dropwise to the first solution prepared in step 1 to prepare a mixed solution;
步骤三、待第二溶液滴加完毕后,步骤二所制备得到的混合溶液在50℃下搅拌48-72h,并将反应完成的混合溶液蒸发溶剂后的残余物通过硅胶柱层析进行纯化干燥得到荧光探针化合物TPE-SDOX。Step 3: After the second solution is added dropwise, the mixed solution prepared in step 2 is stirred at 50° C. for 48-72 hours, and the residue after evaporating the solvent of the mixed solution after the reaction is completed is purified and dried by silica gel column chromatography to obtain the fluorescent probe compound TPE-SDOX.
本发明的目的之三是提供一种微酸环境响应AIE荧光探针的在肿瘤细胞成像中的应用。The third object of the present invention is to provide an application of a slightly acidic environment responsive AIE fluorescent probe in tumor cell imaging.
作为优选方案,所述小分子荧光探针与肿瘤细胞采用共培养的方式,优选的,所述小分子荧光探针采用TPE-SDOX。As a preferred solution, the small molecule fluorescent probe and tumor cells are co-cultured. Preferably, the small molecule fluorescent probe is TPE-SDOX.
与现有技术相比,本发明具有如下有益效果之一:Compared with the prior art, the present invention has one of the following beneficial effects:
其一、本方案的荧光探针展现出良好的生物安全性和较低毒副作用,能够靶向肿瘤酸性微环境进行细胞荧光成像,并具有优异的细胞渗透摄取能力,为靶向肿瘤酸性微环境提供了一种有效的荧光探针化合物。本方案的荧光探针化合物利用磺胺类衍生物在生理范围内的不同的pKa,通过小分子荧光探针化合物的酰胺基团在不同pH环境中质子化和去质子化的过程,实现荧光探针响应肿瘤酸性微环境进行活细胞荧光成像的过程,并成功将pH转变点调整至肿瘤酸性微环境。First, the fluorescent probe of this scheme exhibits good biosafety and low toxic side effects, can target the acidic microenvironment of tumors for cell fluorescence imaging, and has excellent cell penetration and uptake ability, providing an effective fluorescent probe compound for targeting the acidic microenvironment of tumors. The fluorescent probe compound of this scheme utilizes the different pKa of sulfonamide derivatives within the physiological range, and through the process of protonation and deprotonation of the amide group of the small molecule fluorescent probe compound in different pH environments, the process of fluorescent probe responding to the acidic microenvironment of tumors for live cell fluorescence imaging is realized, and the pH transition point is successfully adjusted to the acidic microenvironment of tumors.
其二、本方案优化了荧光探针化合物制备工艺,选择四苯乙烯作为AIE转子,制备了一种具有响应肿瘤酸性微环境的AIE荧光探针,以1,1,2,2-四(4-羧基苯)乙烯(H4TCPE)为代表的AIE分子,通过与磺胺类分子发生酰胺化反应,能够成功制备酸响应的AIE小分子荧光探针,四苯乙烯-苯磺酰胺(TPE-SA)、四苯乙烯-磺胺醋酰(TPE-SAC)和四苯乙烯-磺胺多辛(TPE-SDOX),通过严格控制温度指标和反应时间,减压蒸除溶剂并对残余物进行纯化干燥得到本申请的小分子荧光探针化合物。本方案所制备出的小分子荧光探针通过微酸pH响应基团设计,提升其在肿瘤成像中的检测灵敏度。Second, this scheme optimizes the preparation process of fluorescent probe compounds, selects tetraphenylethylene as the AIE rotor, and prepares an AIE fluorescent probe that responds to the acidic microenvironment of tumors. The AIE molecules represented by 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene (H4TCPE) can successfully prepare acid-responsive AIE small molecule fluorescent probes, tetraphenylethylene-benzenesulfonamide (TPE-SA), tetraphenylethylene-sulfonic acetamide (TPE-SAC) and tetraphenylethylene-sulfadoxine (TPE-SDOX), by undergoing amidation reaction with sulfonamide molecules. The small molecule fluorescent probe compounds of this application are obtained by strictly controlling the temperature index and reaction time, removing the solvent under reduced pressure, and purifying and drying the residue. The small molecule fluorescent probe prepared by this scheme is designed with a slightly acidic pH response group to improve its detection sensitivity in tumor imaging.
其三、本发明制备得到的荧光探针展现出良好的生物安全性和较低毒副作用,能够靶向肿瘤酸性微环境进行细胞荧光成像,并具有优异的细胞渗透摄取能力,为靶向肿瘤酸性微环境提供了一种有效方法,通过荧光探针与肿瘤细胞共培养的方式,调整培养基pH值达到聚集诱导发光成像的效果,具体是在肿瘤微酸环境中,导致酰胺键质子化,整体呈电中性。聚集状态下在细胞内发出明亮荧光,实现对肿瘤细胞安全有效的选择性荧光成像。Third, the fluorescent probe prepared by the present invention exhibits good biosafety and low toxic side effects, can target the acidic microenvironment of tumors for cell fluorescence imaging, and has excellent cell penetration and uptake ability, providing an effective method for targeting the acidic microenvironment of tumors. By co-culturing fluorescent probes with tumor cells, the pH value of the culture medium is adjusted to achieve the effect of aggregation-induced luminescence imaging, specifically in the slightly acidic environment of tumors, resulting in the protonation of amide bonds and overall neutrality. Bright fluorescence is emitted in the cell in the aggregated state, achieving safe and effective selective fluorescence imaging of tumor cells.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为本发明中H4TCPE的核磁氢谱图;Fig. 1 is the nuclear magnetic hydrogen spectrum of H4TCPE in the present invention;
图2为本发明实施例所制备TPE-SA的核磁氢谱图;FIG2 is a hydrogen NMR spectrum of TPE-SA prepared in an embodiment of the present invention;
图3为本发明实施例所制备TPE-SAC的核磁氢谱图;FIG3 is a hydrogen NMR spectrum of TPE-SAC prepared in an embodiment of the present invention;
图4为本发明实施例所制备TPE-SDOX的核磁氢谱图;FIG4 is a hydrogen NMR spectrum of TPE-SDOX prepared in an embodiment of the present invention;
图5为H4TCPE在含不同体积分数水的DMSO/H2O混合物中的FL光谱图;FIG5 is a FL spectrum of H4TCPE in DMSO/H2O mixtures containing different volume fractions of water;
图6为H4TCPE在含不同体积分数水的DMSO/H2O混合物中的相对FL强度图;FIG6 is a graph showing the relative FL intensity of H4TCPE in DMSO/H2O mixtures containing different volume fractions of water;
图7为TPE-SA在含不同体积分数水的DMSO/H2O混合物中的FL光谱图;FIG7 is a FL spectrum of TPE-SA in DMSO/H2O mixtures containing different volume fractions of water;
图8为TPE-SA在含不同体积分数水的DMSO/H2O混合物中的相对FL强度图;FIG8 is a graph showing the relative FL intensity of TPE-SA in DMSO/H2O mixtures containing different volume fractions of water;
图9为TPE-SAC在含不同体积分数水的DMSO/H2O混合物中的FL光谱图;FIG9 is a FL spectrum of TPE-SAC in DMSO/H2O mixtures containing different volume fractions of water;
图10为TPE-SAC在含不同体积分数水的DMSO/H2O混合物中的相对FL强度图;FIG10 is a graph showing the relative FL intensity of TPE-SAC in DMSO/H2O mixtures containing different volume fractions of water;
图11为TPE-SDOX在含不同体积分数水的DMSO/H2O混合物中的FL光谱图;FIG11 is a FL spectrum of TPE-SDOX in DMSO/H2O mixtures containing different volume fractions of water;
图12为TPE-SDOX在含不同体积分数水的DMSO/H2O混合物中的相对FL强度图;FIG12 is a graph showing the relative FL intensity of TPE-SDOX in DMSO/H2O mixtures containing different volume fractions of water;
图13为不同pH值缓冲液的H4TCPE的荧光光谱;FIG13 is the fluorescence spectra of H4TCPE in buffers with different pH values;
图14为H4TCPE荧光强度随pH值变化图;FIG14 is a graph showing the change in fluorescence intensity of H4TCPE with pH value;
图15为H4TCPE在不同pH缓冲液中的荧光特性。FIG15 shows the fluorescence characteristics of H4TCPE in buffer solutions with different pH values.
图16为不同pH值缓冲液的TPE-SA的荧光光谱;FIG16 is the fluorescence spectra of TPE-SA in buffers with different pH values;
图17为TPE-SA荧光强度随pH值变化图;FIG17 is a graph showing the change in fluorescence intensity of TPE-SA with pH value;
图18为TPE-SA在不同pH缓冲液中的荧光特性;FIG18 shows the fluorescence characteristics of TPE-SA in different pH buffers;
图19为不同pH值缓冲液的TPE-SAC的荧光光谱;FIG19 is the fluorescence spectra of TPE-SAC in buffers with different pH values;
图20为TPE-SAC荧光强度随pH值变化图;FIG20 is a graph showing the change in fluorescence intensity of TPE-SAC with pH value;
图21为TPE-SAC在不同pH缓冲液中的荧光特性;FIG21 shows the fluorescence characteristics of TPE-SAC in different pH buffers;
图22为不同pH值缓冲液的TPE-SDOX的荧光光谱;FIG22 is the fluorescence spectra of TPE-SDOX in buffers with different pH values;
图23为TPE-SDOX荧光强度随pH值变化图;FIG23 is a graph showing the change in fluorescence intensity of TPE-SDOX with pH value;
图24为TPE-SDOX在不同pH缓冲液中的荧光特性;FIG24 shows the fluorescence characteristics of TPE-SDOX in different pH buffers;
图25为将H4TCPE母液与pH为4.96的PBS缓冲液、DMEM溶液分别混合配制成含水量98%的溶液;根据最大荧光发射强度所绘制的荧光强度与时间的关系图;FIG25 is a graph showing the relationship between fluorescence intensity and time obtained by mixing H4TCPE mother solution with PBS buffer solution having a pH of 4.96 and DMEM solution to prepare a solution having a water content of 98%; FIG25 is a graph showing the relationship between fluorescence intensity and time obtained by plotting the maximum fluorescence emission intensity;
图26为将TPE-SA母液与pH为5.75的PBS缓冲液、DMEM溶液分别混合配制成含水量98%的溶液;根据最大荧光发射强度绘制荧光强度与时间的关系图;FIG26 is a graph showing the relationship between fluorescence intensity and time, in which the TPE-SA mother solution was mixed with a PBS buffer solution having a pH of 5.75 and a DMEM solution to prepare a solution having a water content of 98%; and the maximum fluorescence emission intensity was plotted;
图27为将TPE-SAC与pH为6.27的PBS缓冲液、DMEM溶液分别混合配制成含水量98%的溶液;根据最大荧光发射强度绘制荧光强度与时间的关系图;FIG27 is a graph showing the relationship between fluorescence intensity and time, in which TPE-SAC is mixed with a PBS buffer solution having a pH of 6.27 and a DMEM solution to prepare a solution having a water content of 98%; and the maximum fluorescence emission intensity is plotted;
图28为将TPE-SDOX与pH为6.7的PBS缓冲液、DMEM溶液分别混合配制成含水量98%的溶液;根据最大荧光发射强度绘制荧光强度与时间的关系图;FIG28 is a graph showing the relationship between fluorescence intensity and time, in which TPE-SDOX is mixed with a PBS buffer solution having a pH of 6.7 and a DMEM solution to prepare a solution having a water content of 98%; and the maximum fluorescence emission intensity is plotted;
图29为H4TCPE母液在pH4.0和5.5之间根据最大荧光发射强度绘制荧光强度与循环次数的关系图;FIG29 is a graph showing the relationship between fluorescence intensity and cycle number when the H4TCPE mother solution is between pH 4.0 and 5.5 and plotted based on the maximum fluorescence emission intensity;
图30为TPE-SA母液在pH5.0和6.0之间根据最大荧光发射强度绘制荧光强度与循环次数的关系图;FIG30 is a graph showing the relationship between fluorescence intensity and cycle number when the maximum fluorescence emission intensity is plotted for TPE-SA mother solution between pH 5.0 and 6.0;
图31为TPE-SAC母液在pH5.5和6.5之间根据最大荧光发射强度绘制荧光强度与循环次数的关系图;FIG31 is a graph showing the relationship between fluorescence intensity and cycle number when the TPE-SAC mother solution is between pH 5.5 and 6.5 and plotted based on the maximum fluorescence emission intensity;
图32为TPE-SDOX母液在pH6.5和7.4之间根据最大荧光发射强度绘制荧光强度与循环次数的关系图;FIG32 is a graph showing the relationship between fluorescence intensity and cycle number when the TPE-SDOX mother solution is between pH 6.5 and 7.4 and plotted based on the maximum fluorescence emission intensity;
图33为不同浓度小分子荧光探针对L02细胞毒性的影响图;FIG33 is a graph showing the effect of different concentrations of small molecule fluorescent probes on the cytotoxicity of L02 cells;
图34为不同浓度小分子荧光探针对HepG2细胞毒性的影响图;FIG34 is a graph showing the effect of different concentrations of small molecule fluorescent probes on the cytotoxicity of HepG2 cells;
图35为H4TCPE处理后HepG2和L02细胞的荧光图像;比例尺:20μm;FIG35 is a fluorescence image of HepG2 and L02 cells after H4TCPE treatment; scale bar: 20 μm;
图36为TPE-SDOX处理后HepG2和L02细胞的荧光图像;比例尺:20μm。FIG. 36 is a fluorescence image of HepG2 and L02 cells after TPE-SDOX treatment; scale bar: 20 μm.
具体实施方式DETAILED DESCRIPTION
为使本发明实现的技术手段、创作特征、达成目的以及有益效果易于明白了解,下面结合具体实施方式,进一步阐述本发明。In order to make the technical means, creative features, objectives and beneficial effects achieved by the present invention easy to understand, the present invention is further explained below in conjunction with specific implementation methods.
另外,为了更好说明本发明,在下文的具体实施方式中给出了众多的具体细节,本领域技术人员应当理解,没有某些具体细节,本发明同样可以实施,在另外一些实施例中,对于本领域技术人员熟知的方法、手段、器材和步骤未作详细描述,以便于凸显本发明的主旨。In addition, in order to better illustrate the present invention, numerous specific details are given in the specific embodiments below. Those skilled in the art should understand that the present invention can also be implemented without certain specific details. In other embodiments, methods, means, equipment and steps well known to those skilled in the art are not described in detail in order to highlight the main purpose of the present invention.
本发明提供一种AIE荧光探针及其微酸环境响应AIE荧光探针的制备方法,包括如下步骤:步骤一、将磺胺类化合物溶于一定量的无水四氢呋喃中,并按照比例加入三乙胺,置于冰水浴搅拌10-30min,得到第一溶液;步骤二、将一定量的酰氯固体溶于一定量的无水四氢呋喃中得到第二溶液,并将第二溶液滴加至步骤一所得的第一溶液中,从而制备混合溶液。本步骤二中所用的酰氯固体的制备方法如下:将1,1,2,2-四(4-羧基苯)乙烯溶于SOCl2,其中每1g1,1,2,2-四(4-羧基苯)乙烯投加在70-100mL的二氯亚砜(SOCl2)中,在回流温度下反应24-48h进行活化;待活化反应结束后,冷却至室温,减压蒸发除去溶剂得到固体酰氯;步骤三、待第二溶液滴加完毕后,将步骤二所制备得到的混合溶液在25-50℃下搅拌48-72h后,蒸发溶剂后的残余物通过硅胶柱层析进行纯化干燥得到对应的荧光探针化合物。The present invention provides an AIE fluorescent probe and a preparation method of the slightly acidic environment responsive AIE fluorescent probe, comprising the following steps: step 1, dissolving a sulfonamide compound in a certain amount of anhydrous tetrahydrofuran, adding triethylamine according to a proportion, placing the mixture in an ice-water bath and stirring for 10-30 minutes to obtain a first solution; step 2, dissolving a certain amount of acyl chloride solid in a certain amount of anhydrous tetrahydrofuran to obtain a second solution, and dropping the second solution into the first solution obtained in step 1 to prepare a mixed solution. The preparation method of the acyl chloride solid used in step 2 is as follows: dissolving 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene in SOCl 2 , wherein 1g of 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene is added into 70-100mL of dichlorothionyl (SOCl 2 ), and reacting at reflux temperature for 24-48h for activation; after the activation reaction is completed, cooling to room temperature, and evaporating under reduced pressure to remove the solvent to obtain solid acyl chloride; step 3, after the second solution is added dropwise, stirring the mixed solution prepared in step 2 at 25-50° C. for 48-72h, and purifying the residue after evaporating the solvent by silica gel column chromatography and drying to obtain the corresponding fluorescent probe compound.
其中,上述步骤中的1,1,2,2-四(4-羧基苯)乙烯:磺胺类化合物:三乙胺的摩尔比范围为1:4-8:8-12,所述磺胺类化合物选自苯磺酰胺、磺胺醋酰或磺胺多辛中的一种;优选的,磺胺类化合物采用磺胺多辛。Wherein, the molar ratio of 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene:sulfonamide compound:triethylamine in the above steps is in the range of 1:4-8:8-12, and the sulfonamide compound is selected from one of benzenesulfonamide, sulfacetamide or sulfadoxine; preferably, the sulfonamide compound is sulfadoxine.
本发明,磺胺类化合物采用苯磺酰胺,步骤三中所得产物,在减压蒸发溶剂后,残余物通过硅胶柱层析(DCM∶MeOH=5∶1)进行纯化干燥得到TPE-SA。In the present invention, the sulfonamide compound is benzenesulfonamide. After the solvent is evaporated under reduced pressure, the residue is purified and dried by silica gel column chromatography (DCM: MeOH = 5: 1) to obtain TPE-SA.
本发明,磺胺类化合物为磺胺醋酰,步骤三中所得产物,在减压蒸发溶剂后,残余物通过硅胶柱层析(DCM∶MeOH=5∶1)进行纯化干燥得到TPE-SAC。In the present invention, the sulfonamide compound is sulfacetamide. After the solvent is evaporated under reduced pressure, the residue obtained in step 3 is purified and dried by silica gel column chromatography (DCM: MeOH = 5: 1) to obtain TPE-SAC.
优选的,磺胺类化合物为磺胺多辛,步骤三中所得产物,在减压蒸发溶剂后,残余物通过硅胶柱层析(EtOAc:DCM=10:1)进行纯化干燥得到TPE-SDOX。Preferably, the sulfonamide compound is sulfadoxine. After the solvent is evaporated under reduced pressure, the residue of the product obtained in step 3 is purified and dried by silica gel column chromatography (EtOAc:DCM=10:1) to obtain TPE-SDOX.
优选的,荧光探针溶液的工作浓度为:将TPE分子与磺胺类化合物合成的荧光探针,以20μM的浓度溶解在DMSO中。Preferably, the working concentration of the fluorescent probe solution is: the fluorescent probe synthesized by TPE molecules and sulfonamide compounds is dissolved in DMSO at a concentration of 20 μM.
实施例1Example 1
将1,1,2,2-四(4-羧基苯)乙烯(0.1g,0.196mmol)溶于SOCl2(8mL)在回流温度下反应48h,冷却至室温,减压蒸发除去溶剂得到固体酰氯。1,1,2,2-Tetra(4-carboxyphenyl)ethylene (0.1 g, 0.196 mmol) was dissolved in SOCl 2 (8 mL) and reacted at reflux temperature for 48 h, cooled to room temperature, and the solvent was evaporated under reduced pressure to obtain a solid acid chloride.
实施例2Example 2
将1,1,2,2-四(4-羧基苯)乙烯(0.1g,0.196mmol)溶于SOCl2(10mL)在回流温度下反应24h,冷却至室温,减压蒸发除去溶剂得到固体酰氯。1,1,2,2-Tetra(4-carboxyphenyl)ethylene (0.1 g, 0.196 mmol) was dissolved in SOCl 2 (10 mL) and reacted at reflux temperature for 24 h, cooled to room temperature, and the solvent was evaporated under reduced pressure to obtain a solid acid chloride.
实施例3Example 3
将1,1,2,2-四(4-羧基苯)乙烯(0.1g,0.196mmol)溶于SOCl2(7mL)在回流温度下反应48h,冷却至室温,减压蒸发除去溶剂得到固体酰氯。1,1,2,2-Tetra(4-carboxyphenyl)ethylene (0.1 g, 0.196 mmol) was dissolved in SOCl 2 (7 mL) and reacted at reflux temperature for 48 h, cooled to room temperature, and the solvent was evaporated under reduced pressure to obtain a solid acid chloride.
其中,实施例1-3的反应方程式如下:Wherein, the reaction equation of embodiment 1-3 is as follows:
实施例4Example 4
将1,1,2,2-四(4-羧基苯)乙烯(0.1g,0.196mmol)溶于SOCl2(8mL)在回流温度(80℃)条件下反应48h。冷却至室温,减压蒸发除去溶剂得到固体酰氯。将磺胺多辛(0.366g,1.176mmol)溶于无水四氢呋喃(3mL),并加入三乙胺(0.218mL,1.568mmol)得到第一溶液,将所得第一溶液置于冰水浴搅拌30min。将前述制备所得固体酰氯全部溶于3mL无水四氢呋喃后得到第二溶液,将所得到第二溶液逐滴滴加至上述所得第一溶液中得到混合溶液。混合溶液在50℃下搅拌72h后减压蒸发溶剂。随后,蒸除溶剂后的残余物通过硅胶柱层析(EtOAc:DCM=10:1)进行纯化干燥得到TPE-SDOX,产物质量为0.257g,产物产率为77.85%,产物纯度为85.26%。Dissolve 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene (0.1 g, 0.196 mmol) in SOCl 2 (8 mL) and react at reflux temperature (80 ° C) for 48 h. Cool to room temperature, evaporate the solvent under reduced pressure to obtain a solid acid chloride. Dissolve sulfadoxine (0.366 g, 1.176 mmol) in anhydrous tetrahydrofuran (3 mL), add triethylamine (0.218 mL, 1.568 mmol) to obtain a first solution, and place the obtained first solution in an ice-water bath and stir for 30 min. Dissolve all the solid acid chloride prepared above in 3 mL of anhydrous tetrahydrofuran to obtain a second solution, and add the obtained second solution dropwise to the above-obtained first solution to obtain a mixed solution. Stir the mixed solution at 50 ° C for 72 h, and evaporate the solvent under reduced pressure. Subsequently, the residue after evaporating the solvent was purified and dried by silica gel column chromatography (EtOAc:DCM=10:1) to obtain TPE-SDOX. The product mass was 0.257 g, the product yield was 77.85%, and the product purity was 85.26%.
实施例5Example 5
将1,1,2,2-四(4-羧基苯)乙烯(0.1g,0.196mmol)溶于SOCl2(8mL)在回流温度(80℃)下反应48h。冷却至室温,减压蒸发除去溶剂得到固体酰氯。将磺胺多辛(0.244g,0.784mmol)溶于无水四氢呋喃(3mL),并加入三乙胺(0.272mL,1.96mmol)得到第一溶液,将所得第一溶液置于冰水浴搅拌30min。将前述制备所得固体酰氯全部溶于3mL无水四氢呋喃后得到第二溶液,将所得到第二溶液逐滴滴加至上述所得第一溶液中得到混合溶液。混合溶液在50℃下搅拌60h后减压蒸发溶剂。随后,蒸除溶剂后的残余物通过硅胶柱层析(EtOAc:DCM=10:1)进行纯化干燥得到TPE-SDOX,产物质量为0.2214g,产物产率为67.07%,产物纯度为80.26%。Dissolve 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene (0.1 g, 0.196 mmol) in SOCl 2 (8 mL) and react at reflux temperature (80 ° C) for 48 h. Cool to room temperature, evaporate the solvent under reduced pressure to obtain a solid acid chloride. Dissolve sulfadoxine (0.244 g, 0.784 mmol) in anhydrous tetrahydrofuran (3 mL), and add triethylamine (0.272 mL, 1.96 mmol) to obtain a first solution, and place the obtained first solution in an ice-water bath and stir for 30 min. Dissolve all the solid acid chloride prepared above in 3 mL of anhydrous tetrahydrofuran to obtain a second solution, and add the obtained second solution dropwise to the above-obtained first solution to obtain a mixed solution. Stir the mixed solution at 50 ° C for 60 h, and then evaporate the solvent under reduced pressure. Subsequently, the residue after evaporating the solvent was purified and dried by silica gel column chromatography (EtOAc:DCM=10:1) to obtain TPE-SDOX. The product mass was 0.2214 g, the product yield was 67.07%, and the product purity was 80.26%.
实施例6Example 6
将1,1,2,2-四(4-羧基苯)乙烯(0.1g,0.196mmol)溶于SOCl2(8mL)在回流温度下反应48h。冷却至室温,减压蒸发除去溶剂得到固体酰氯。将磺胺多辛(0.366g,1.176mmol)溶于无水四氢呋喃(3mL),并加入三乙胺(0.218mL,1.568mmol)得到第一溶液,将所得第一溶液置于冰水浴搅拌30min。将前述制备所得固体酰氯全部溶于3mL无水四氢呋喃后得到第二溶液,将所得到第二溶液逐滴滴加至上述所得第一溶液中得到混合溶液。混合溶液在50℃下搅拌48h后减压蒸发溶剂。随后,蒸除溶剂后的残余物通过硅胶柱层析(EtOAc:DCM=10:1)进行纯化干燥得到TPE-SDOX,产物质量为0.269g,产物产率为81.49%,产物纯度为89.6%。Dissolve 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene (0.1 g, 0.196 mmol) in SOCl 2 (8 mL) and react at reflux temperature for 48 h. Cool to room temperature, evaporate the solvent under reduced pressure to obtain a solid acid chloride. Dissolve sulfadoxine (0.366 g, 1.176 mmol) in anhydrous tetrahydrofuran (3 mL), add triethylamine (0.218 mL, 1.568 mmol) to obtain a first solution, and place the obtained first solution in an ice-water bath and stir for 30 min. Dissolve all the solid acid chloride prepared above in 3 mL of anhydrous tetrahydrofuran to obtain a second solution, and add the obtained second solution dropwise to the above-obtained first solution to obtain a mixed solution. Stir the mixed solution at 50°C for 48 h, and evaporate the solvent under reduced pressure. Subsequently, the residue after evaporating the solvent was purified and dried by silica gel column chromatography (EtOAc:DCM=10:1) to obtain TPE-SDOX. The product mass was 0.269 g, the product yield was 81.49%, and the product purity was 89.6%.
实施例7Example 7
将1,1,2,2-四(4-羧基苯)乙烯(0.1g,0.196mmol)溶于SOCl2(8mL)在回流温度下反应48h。冷却至室温,减压蒸发除去溶剂得到固体酰氯。将磺胺多辛(0.488g,1.568mmol)溶于无水四氢呋喃(3mL),并加入三乙胺(0.327mL,2.352mmol)得到第一溶液,置于冰水浴搅拌30min。将所得固体酰氯全部溶于3mL无水四氢呋喃后得到第二溶液,将所得到第二溶液逐滴滴加至上述第一溶液中得到混合溶液。混合溶液在50℃下搅拌72h后减压蒸发溶剂。随后,蒸除溶剂后的残余物通过硅胶柱层析(EtOAc:DCM=10:1)进行纯化干燥得到TPE-SDOX,产物质量为0.249g,产物产率为75.4%,产物纯度为87.9%。Dissolve 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene (0.1 g, 0.196 mmol) in SOCl 2 (8 mL) and react at reflux temperature for 48 h. Cool to room temperature and evaporate the solvent under reduced pressure to obtain a solid acid chloride. Dissolve sulfadoxine (0.488 g, 1.568 mmol) in anhydrous tetrahydrofuran (3 mL) and add triethylamine (0.327 mL, 2.352 mmol) to obtain a first solution, which is placed in an ice-water bath and stirred for 30 min. Dissolve the obtained solid acid chloride in 3 mL of anhydrous tetrahydrofuran to obtain a second solution, and add the obtained second solution dropwise to the above-mentioned first solution to obtain a mixed solution. Stir the mixed solution at 50°C for 72 h and evaporate the solvent under reduced pressure. Subsequently, the residue after evaporating the solvent was purified and dried by silica gel column chromatography (EtOAc:DCM=10:1) to obtain TPE-SDOX. The product mass was 0.249 g, the product yield was 75.4%, and the product purity was 87.9%.
其中,实施例4-7的反应式如下:Wherein, the reaction formula of embodiment 4-7 is as follows:
图4为实施例7中所制备TPE-SDOX(以氘代二甲基亚砜为溶剂)的核磁氢谱图。FIG4 is a hydrogen NMR spectrum of TPE-SDOX prepared in Example 7 (using deuterated dimethyl sulfoxide as solvent).
实施例8Example 8
将1,1,2,2-四(4-羧基苯)乙烯(0.1g,0.196mmol)溶于SOCl2(8mL)在回流温度下反应48h。冷却至室温,减压蒸发除去溶剂得到固体酰氯。将苯磺酰胺(0.185g,1.176mmol)溶于无水四氢呋喃(3mL),并加入三乙胺(0.218mL,1.568mmol)得到第一溶液,将所得第一溶液置于冰水浴搅拌30min。将前述制备所得的酰氯固体全部溶于3mL无水四氢呋喃后得到第二溶液,将所得到第二溶液逐滴滴加至上述第一溶液中得到混合溶液。将混合溶液在室温下搅拌72h后减压蒸发溶剂。随后,蒸除溶剂后的残余物通过硅胶柱层析(DCM∶MeOH=5∶1)进行纯化干燥得到TPE-SA,产物质量为0.165g,产物产率为78.7%,产物纯度为91.6%,其反应方程式如下:Dissolve 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene (0.1 g, 0.196 mmol) in SOCl 2 (8 mL) and react at reflux temperature for 48 h. Cool to room temperature, evaporate the solvent under reduced pressure to obtain solid acid chloride. Dissolve benzenesulfonamide (0.185 g, 1.176 mmol) in anhydrous tetrahydrofuran (3 mL), add triethylamine (0.218 mL, 1.568 mmol) to obtain a first solution, and place the obtained first solution in an ice-water bath and stir for 30 min. Dissolve all the acid chloride solids prepared above in 3 mL of anhydrous tetrahydrofuran to obtain a second solution, and add the obtained second solution dropwise to the above first solution to obtain a mixed solution. Stir the mixed solution at room temperature for 72 h and evaporate the solvent under reduced pressure. Subsequently, the residue after evaporation of the solvent was purified and dried by silica gel column chromatography (DCM: MeOH = 5: 1) to obtain TPE-SA. The product mass was 0.165 g, the product yield was 78.7%, and the product purity was 91.6%. The reaction equation is as follows:
图2为实施例8所制备的TPE-SA(以氘代二甲基亚砜为溶剂)的核磁氢谱图。FIG2 is a hydrogen NMR spectrum of TPE-SA prepared in Example 8 (using deuterated dimethyl sulfoxide as solvent).
实施例9Example 9
将1,1,2,2-四(4-羧基苯)乙烯(0.1g,0.196mmol)溶于SOCl2(8mL)在回流温度下反应48h。冷却至室温,减压蒸发除去溶剂得到固体酰氯。将磺胺醋酰(0.253g,1.176mmol)溶于无水四氢呋喃(3mL),并加入三乙胺(0.218mL,1.568mmol)得到第一溶液,将所得第一溶液置于冰水浴搅拌30min。将上述制备所得固体酰氯全部溶于3mL无水四氢呋喃后得到第二溶液,将所得到第二溶液逐滴滴加至上述第一溶液中得到混合溶液。混合溶液在50℃下搅拌72h后减压蒸发溶剂。随后,蒸除溶剂后的残余物通过硅胶柱层析(DCM:MeOH=5:1)进行纯化干燥得到TPE-SAC,产物质量0.179g,产物产率为70.3%,产物纯度为86.4%。其反应式如下:Dissolve 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene (0.1 g, 0.196 mmol) in SOCl 2 (8 mL) and react at reflux temperature for 48 h. Cool to room temperature and evaporate the solvent under reduced pressure to obtain a solid acid chloride. Dissolve sulfacetamide (0.253 g, 1.176 mmol) in anhydrous tetrahydrofuran (3 mL) and add triethylamine (0.218 mL, 1.568 mmol) to obtain a first solution, and place the obtained first solution in an ice-water bath and stir for 30 min. Dissolve all the solid acid chloride prepared above in 3 mL of anhydrous tetrahydrofuran to obtain a second solution, and add the obtained second solution dropwise to the above first solution to obtain a mixed solution. Stir the mixed solution at 50°C for 72 h and evaporate the solvent under reduced pressure. Subsequently, the residue after evaporation of the solvent was purified and dried by silica gel column chromatography (DCM: MeOH = 5: 1) to obtain TPE-SAC, with a product mass of 0.179 g, a product yield of 70.3%, and a product purity of 86.4%. The reaction formula is as follows:
图3为实施例9制备的TPE-SAC(以氘代二甲基亚砜为溶剂)的核磁氢谱图。FIG3 is a hydrogen NMR spectrum of TPE-SAC prepared in Example 9 (using deuterated dimethyl sulfoxide as solvent).
比较例1Comparative Example 1
将1,1,2,2-四(4-羧基苯)乙烯(0.1g,0.196mmol)溶于SOCl2(8mL)在回流温度下反应48h。冷却至室温,减压蒸发除去溶剂得到固体酰氯。将磺胺噻唑(0.301g,1.176mmol)溶于无水四氢呋喃(3mL),并加入三乙胺(0.218mL,1.568mmol)得到第一溶液,将所得第一溶液置于冰水浴搅拌30min。将上述所得固体酰氯全部溶于3mL无水四氢呋喃后得到第二溶液,将所得到第二溶液逐滴滴加至上述第一溶液中得到混合溶液。混合溶液在50℃下搅拌72h后减压蒸发溶剂。随后,蒸除溶剂后的残余物通过硅胶柱层析进行纯化干燥得到TPE-STZ,产物质量0.207g,产物产率72%,产物纯度79.94%。其反应式如下: 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene (0.1g, 0.196mmol) was dissolved in SOCl 2 (8mL) and reacted at reflux temperature for 48h. After cooling to room temperature, the solvent was evaporated under reduced pressure to obtain a solid acid chloride. Sulfathiazole (0.301g, 1.176mmol) was dissolved in anhydrous tetrahydrofuran (3mL), and triethylamine (0.218mL, 1.568mmol) was added to obtain a first solution, and the obtained first solution was placed in an ice-water bath and stirred for 30min. The above-obtained solid acid chloride was completely dissolved in 3mL of anhydrous tetrahydrofuran to obtain a second solution, and the obtained second solution was added dropwise to the above-obtained first solution to obtain a mixed solution. The mixed solution was stirred at 50°C for 72h and the solvent was evaporated under reduced pressure. Subsequently, the residue after evaporation of the solvent was purified and dried by silica gel column chromatography to obtain TPE-STZ, with a product mass of 0.207g, a product yield of 72%, and a product purity of 79.94%. The reaction formula is as follows:
比较例2Comparative Example 2
将1,1,2,2-四(4-羧基苯)乙烯(0.1g,0.196mmol)溶于SOCl2(8mL)在回流温度下反应48h。冷却至室温,减压蒸发除去溶剂得到固体酰氯。将磺胺二甲嘧啶(0.328g,1.176mmol)溶于无水四氢呋喃(3mL),并加入三乙胺(0.218mL,1.568mmol)得到第一溶液,将所得第一溶液置于冰水浴搅拌30min。将上述所得固体酰氯全部溶于3mL无水四氢呋喃后得到第二溶液,将所得到第二溶液逐滴滴加至上述第一溶液中得到混合溶液。混合溶液在50℃下搅拌72h后减压蒸发溶剂。随后,残余物通过硅胶柱层析进行纯化干燥得到TPE-SMZ,产物质量0.235g,产物产率77.02%,产物纯度为67.63%。其反应方程式如下:1,1,2,2-tetrakis(4-carboxyphenyl)ethylene (0.1 g, 0.196 mmol) was dissolved in SOCl 2 (8 mL) and reacted at reflux temperature for 48 h. After cooling to room temperature, the solvent was evaporated under reduced pressure to obtain a solid acid chloride. Sulfadimethoxine (0.328 g, 1.176 mmol) was dissolved in anhydrous tetrahydrofuran (3 mL), and triethylamine (0.218 mL, 1.568 mmol) was added to obtain a first solution, and the obtained first solution was placed in an ice-water bath and stirred for 30 min. The above-obtained solid acid chloride was completely dissolved in 3 mL of anhydrous tetrahydrofuran to obtain a second solution, and the obtained second solution was added dropwise to the above-obtained first solution to obtain a mixed solution. The mixed solution was stirred at 50 ° C for 72 h and then the solvent was evaporated under reduced pressure. Subsequently, the residue was purified and dried by silica gel column chromatography to obtain TPE-SMZ, with a product mass of 0.235 g, a product yield of 77.02%, and a product purity of 67.63%. The reaction equation is as follows:
本方案,通过1H NMR和FTIR表征证实了荧光探针的成功制备;通过荧光分光光度计测得不同含水量溶液的荧光强度,证实了TPE-SA、TPE-SAC和TPE-SDOX具有优异的AIE效应;进一步在不同pH缓冲溶液中测量荧光强度,发现TPE-SA、TPE-SAC和TPE-SDOX的pH转变点分别在5.76±0.02、6.09±0.03和6.83±0.02,证明通过磺胺类基团对TPE分子进行修饰,将H4TCPE聚集发光响应的pH转变点调整至肿瘤微环境。In this scheme, the successful preparation of the fluorescent probe was confirmed by 1 H NMR and FTIR characterization; the fluorescence intensity of solutions with different water contents was measured by fluorescence spectrophotometer, confirming that TPE-SA, TPE-SAC and TPE-SDOX had excellent AIE effect; the fluorescence intensity was further measured in different pH buffer solutions, and it was found that the pH transition points of TPE-SA, TPE-SAC and TPE-SDOX were 5.76±0.02, 6.09±0.03 and 6.83±0.02, respectively, proving that the pH transition point of the H4TCPE aggregation luminescence response was adjusted to the tumor microenvironment by modifying the TPE molecules with sulfonamide groups.
本方案中,上述实施例4-9通过酰胺化反应将TPE与磺酰胺类化合物结合,成功合成了TPE-SA、TPE-SAC和TPE-SDOX,其中实施例4-7中的TPE-SDOX通过将pH转变点调整至肿瘤微酸环境,使AIE现象发生在肿瘤部位,用于肿瘤细胞成像。将所得荧光探针化合物其溶解在溶剂中,注射到肿瘤部位,能够制备得到微酸响应性智能荧光成像探针,本方案是采用将小分子荧光探针与肿瘤细胞共孵育后,能够实现电荷快速转换,以增强细胞摄取和与癌细胞孵育时精确的荧光成像。小分子荧光探针到达肿瘤部位,在肿瘤微酸环境中,导致酰胺键质子化,形成CONH2+,引入正电荷,而C=O和S=O=S为吸电子基团,整体呈现电中性。聚集状态下,分子内旋转受到限制,导致激发态的能量以发光形式释放,导致在细胞内可以发出明亮的荧光。TPE-SDOX探针展现出灵敏的pH响应及优越的AIE效应,实现对肿瘤细胞安全有效的选择性荧光成像。In this scheme, the above-mentioned Example 4-9 combines TPE with sulfonamide compounds through an amidation reaction, and successfully synthesizes TPE-SA, TPE-SAC and TPE-SDOX, wherein the TPE-SDOX in Example 4-7 adjusts the pH transition point to the slightly acidic environment of the tumor, so that the AIE phenomenon occurs at the tumor site, which is used for tumor cell imaging. The obtained fluorescent probe compound is dissolved in a solvent and injected into the tumor site to prepare a slightly acid-responsive intelligent fluorescent imaging probe. This scheme adopts the method of co-incubating small molecule fluorescent probes with tumor cells to achieve rapid charge conversion to enhance cell uptake and accurate fluorescence imaging during incubation with cancer cells. When the small molecule fluorescent probe reaches the tumor site, it causes the amide bond to be protonated in the slightly acidic environment of the tumor, forming CONH 2+ , introducing a positive charge, while C=O and S=O=S are electron-withdrawing groups, and the whole is electrically neutral. In the aggregated state, the intramolecular rotation is restricted, resulting in the release of the energy of the excited state in the form of luminescence, resulting in bright fluorescence in the cell. The TPE-SDOX probe exhibits sensitive pH response and superior AIE effect, achieving safe and effective selective fluorescence imaging of tumor cells.
生物相容性评价Biocompatibility evaluation
本发明将小分子荧光探针与细胞采用共培养的方式,其培养方法为:将HepG2细胞和L02细胞分别在37℃、体积分数5% CO2的培养箱中培养,DMEM培养基中含有10% FBS和1%抗生素(含有100U/mL青霉素和100μg/mL链霉素)。本发明通过将小分子荧光探针与肿瘤细胞共培养的方式,调整培养基pH值达到聚集诱导发光成像的效果。The present invention co-cultures small molecule fluorescent probes with cells, and the culture method is as follows: HepG2 cells and L02 cells are cultured in an incubator at 37°C and 5% CO2 , respectively, and the DMEM culture medium contains 10% FBS and 1% antibiotics (containing 100U/mL penicillin and 100μg/mL streptomycin). The present invention co-cultures small molecule fluorescent probes with tumor cells and adjusts the pH value of the culture medium to achieve the effect of aggregation-induced luminescence imaging.
MTT(3-(4,5-二甲基噻唑-2-基)-2,5-二苯基-2H-四唑溴化物)作为常用的细胞毒性测定方法,用于评估小分子荧光探针对细胞生存能力的影响。T75培养盒中的L02和HepG2细胞长至80%时,加入胰酶将贴壁细胞消化洗涤。加入新鲜培养基将细胞充分大散后,以8000个细胞/孔的浓度将其接种至96孔板,保持每孔最终培养基体积为200μL。培养24h后,观察到孔内细胞密度达到70%。随后将不同浓度的H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX与细胞混合孵育24h,保持培养基最终浓度为10、20、40、60、80和100μM。随后,每孔加入10μLMTT(5mg/mL)。在CO2培养箱中,37℃孵育4h后,MTT试剂与细胞产生的代谢产物会形成蓝紫色结晶甲瓒散落在培养皿底部。然后,移除培养基,并使用180μL异丙醇将沉积底部的蓝紫色甲瓒晶体溶解。采用ELISA酶标仪测定570nm处的吸光度(OD)值。细胞活性(%)计算公式如下:MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) is a commonly used cytotoxicity assay to evaluate the effects of small molecule fluorescent probes on cell viability. When L02 and HepG2 cells in the T75 culture box grew to 80%, trypsin was added to digest and wash the adherent cells. After adding fresh culture medium to fully disperse the cells, they were inoculated into 96-well plates at a concentration of 8000 cells/well, keeping the final culture medium volume of each well at 200μL. After 24h of culture, it was observed that the cell density in the well reached 70%. Subsequently, different concentrations of H4TCPE, TPE-SA, TPE-SAC and TPE-SDOX were mixed with the cells and incubated for 24h, keeping the final concentration of the culture medium at 10, 20, 40, 60, 80 and 100μM. Subsequently, 10μMTT (5mg/mL) was added to each well. After incubation at 37°C for 4 hours in a CO2 incubator, the MTT reagent and the metabolites produced by the cells will form blue-purple crystalline formazan scattered on the bottom of the culture dish. Then, remove the culture medium and use 180 μL of isopropanol to dissolve the blue-purple formazan crystals deposited at the bottom. Use an ELISA plate reader to measure the absorbance (OD) value at 570 nm. The cell activity (%) calculation formula is as follows:
其中ODsample为经过荧光探针处理后的吸光度,ODcontrol为未经荧光探针处理后的吸光度。细胞毒性实验重复三次。OD sample is the absorbance after treatment with the fluorescent probe, and OD control is the absorbance without treatment with the fluorescent probe. The cytotoxicity experiment was repeated three times.
如图33、34所示,本实施例为体外生物相容性实验实施例,采用MTT法研究H4TCPE、实施例7、8、9的小分子荧光探针对L02和HepG2细胞株的生物相容性。由图分析可知,小分子荧光探针与HepG2和L02细胞共培养24小时后,即使在高达100μM的浓度下,细胞存活率仍保持在90%以上。结果表明,荧光探针对细胞具有较小的毒性。即使在高浓度下AIE荧光探针也能保持细胞活力,为细胞成像提供了良好的生物安全性。As shown in Figures 33 and 34, this embodiment is an in vitro biocompatibility experiment embodiment, and the MTT method is used to study the biocompatibility of H4TCPE, small molecule fluorescent probes of Examples 7, 8, and 9 on L02 and HepG2 cell lines. As can be seen from the figure analysis, after the small molecule fluorescent probe was co-cultured with HepG2 and L02 cells for 24 hours, the cell survival rate remained above 90% even at a concentration of up to 100 μM. The results show that the fluorescent probe has less toxicity to cells. Even at high concentrations, the AIE fluorescent probe can maintain cell viability, providing good biosafety for cell imaging.
细胞摄取情况的评价Evaluation of cellular uptake
为了评估H4TCPE和TPE-SDOX荧光探针的细胞摄取情况,本发明采用荧光倒置显微镜对L02和HepG2细胞进行观察。首先,将盖玻片用王水浸泡并进行高压蒸汽灭菌。然后将盖玻片置于孔板用PBS溶液进行润洗,避免双侧细胞生长影响封片和成像效果。随后每个孔中加入0.5mL培养基,保证细胞可以均匀分散在24孔板。每个孔接种2×105个细胞,孔板内细胞密度达到约70%,可将原始培养基替换为pH调整为6.5的DMEM培养基,加入20μLH4TCPE或TPE-SDOX的DMSO溶液(整个过程是:吸出原始培养基,加入980uL的pH6.5的培养基,加入20uL探针。使整体的总体积为1mL,荧光探针的最终浓度为20uM)。在替换培养基的过程中,使用无菌PBS清洗孔板以减少血清残留。细胞在CO2培养箱中孵育不同时间段后,将孔板中的培养基吸出,并用PBS洗涤三次。随后,加入可覆盖盖玻片的多聚甲醛溶液(4%,PFA)孵育10min,固定细胞。随后将PFA吸出后,用细胞级的PBS缓冲溶液(缓冲液型号为P1020)洗涤三次。在载玻片表面滴加20μL抗荧光猝灭封片液,使用细胞夹将盖玻片取出倒置载玻片上。随后,在盖玻片表面滴上无荧光显微镜镜油,采用荧光倒置显微镜观察细胞摄取情况。In order to evaluate the cellular uptake of H4TCPE and TPE-SDOX fluorescent probes, the present invention uses a fluorescent inverted microscope to observe L02 and HepG2 cells. First, the coverslip is soaked in aqua regia and sterilized with high-pressure steam. Then the coverslip is placed on the well plate and rinsed with PBS solution to avoid bilateral cell growth affecting the sealing and imaging effects. Subsequently, 0.5mL of culture medium is added to each well to ensure that the cells can be evenly dispersed in the 24-well plate. Each well is inoculated with 2×10 5 cells, and the cell density in the well plate reaches about 70%. The original culture medium can be replaced with DMEM culture medium adjusted to pH 6.5, and 20μL of H4TCPE or TPE-SDOX DMSO solution is added (the whole process is: aspirate the original culture medium, add 980uL of pH6.5 culture medium, and add 20uL probe. The total volume of the whole is 1mL, and the final concentration of the fluorescent probe is 20uM). In the process of replacing the culture medium, the well plate is washed with sterile PBS to reduce serum residues. After the cells were incubated in a CO2 incubator for different periods of time, the culture medium in the well plate was aspirated and washed three times with PBS. Subsequently, a polyformaldehyde solution (4%, PFA) that can cover the coverslip was added and incubated for 10 minutes to fix the cells. After the PFA was aspirated, the cells were washed three times with a cell-grade PBS buffer solution (buffer model P1020). 20 μL of anti-fluorescence quenching sealing solution was dripped on the surface of the slide, and the coverslip was removed and inverted on the slide using a cell clamp. Subsequently, non-fluorescence microscope oil was dripped on the surface of the coverslip, and the cell uptake was observed using a fluorescent inverted microscope.
如图35、36所示,本实施例为细胞摄取性能实验实施例,该实施例利用细胞摄取实验以评估实施例7中所制备小分子荧光探针TPE-SDOX对L02正常细胞和HepG2癌细胞的荧光成像效果。与处理后的L02细胞相比,经过TPE-SDOX处理后的HepG2细胞显示出明显增加的荧光亮度。而经过H4TCPE处理后的L02和HepG2细胞均未表现出明显的荧光信号。肿瘤微环境往往偏酸性(约为6.2-6.9),当TPE-SDOX到达肿瘤部位时,更接近TPE-SDOX的pH转换点,因此能够产生更强大、更明显的荧光信号。As shown in Figures 35 and 36, this embodiment is a cell uptake performance experimental embodiment, which uses a cell uptake experiment to evaluate the fluorescence imaging effect of the small molecule fluorescent probe TPE-SDOX prepared in Example 7 on L02 normal cells and HepG2 cancer cells. Compared with the treated L02 cells, the HepG2 cells treated with TPE-SDOX showed a significantly increased fluorescence brightness. However, neither the L02 nor the HepG2 cells treated with H4TCPE showed obvious fluorescence signals. The tumor microenvironment is often acidic (about 6.2-6.9). When TPE-SDOX reaches the tumor site, it is closer to the pH conversion point of TPE-SDOX, so it can produce a stronger and more obvious fluorescence signal.
AIE特性评价AIE characteristics evaluation
如图5-12所示,分别为H4TCPE(a,b)、实施例8制备的TPE-SA(c,d)、实施例9制备的TPE-SAC(e,f)和实施例7制备的TPE-SDOX(g,h)在含不同体积分数水的DMSO/H2O混合物中的FL光谱和相对FL强度图(fw),其中图6、8、10和12的插图图片分别对应为H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX在纯DMSO(水的体积分数为fw=0%)和一定体积的DMSO/H2O混合物(水的体积分数为fw=98%)中的荧光图。图5-12检测条件为:激发波长:365nm,探针在溶液中的浓度为:20μM。检测设备:F96Pro荧光分光光度计(上海棱光技术有限公司)。As shown in Figures 5-12, the FL spectra and relative FL intensity diagrams (fw) of H4TCPE (a, b), TPE-SA prepared in Example 8 (c, d), TPE-SAC prepared in Example 9 (e, f) and TPE-SDOX prepared in Example 7 (g, h) in DMSO/H 2 O mixtures containing different volume fractions of water are shown, respectively, where the inset pictures of Figures 6, 8, 10 and 12 correspond to the fluorescence diagrams of H4TCPE, TPE-SA, TPE-SAC and TPE-SDOX in pure DMSO (volume fraction of water is fw = 0%) and a certain volume of DMSO/H 2 O mixture (volume fraction of water is fw = 98%). The detection conditions of Figures 5-12 are: excitation wavelength: 365nm, and the concentration of the probe in the solution is: 20μM. Detection equipment: F96Pro fluorescence spectrophotometer (Shanghai Lingguang Technology Co., Ltd.).
由图可知,在良溶剂纯DMSO中,小分子荧光探针会产生微弱的荧光发射。然而,在引入不良溶剂水时,小分子荧光探针的荧光强度显著增强。当含水量不断增加时,H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX的荧光强度呈现明显的上升趋势,水的体积分数为fw=98%各个荧光探针溶液的荧光强度分别是含纯DMSO荧光探针溶液中对应荧光强度值的131、98、139和265倍。与纯DMSO溶剂(即水的体积分数为fw=0%)荧光探针溶液相比,以DMSO/H2O混合物(水的体积分数为fw=98%)作为溶剂的小分子荧光探针表现出更强的荧光强度且具有独特的AIE特征。通过365nm紫外灯照射观察H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX溶液的AIE特性。如图6、8、10、12内的插图部分所示,在纯DMSO溶剂中,H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX几乎没有肉眼可见的荧光,但在DMSO/H2O混合物(水的体积分数为fw=98%)作为溶剂时有明显的荧光发射。结果表明通过将不同磺胺基团与TPE通过酰胺化反应合成的小分子荧光探针保持着TPE分子本身优异的AIE特性。As can be seen from the figure, in the good solvent pure DMSO, the small molecule fluorescent probe will produce weak fluorescence emission. However, when the poor solvent water is introduced, the fluorescence intensity of the small molecule fluorescent probe is significantly enhanced. When the water content continues to increase, the fluorescence intensity of H4TCPE, TPE-SA, TPE-SAC and TPE-SDOX shows a clear upward trend. The fluorescence intensity of each fluorescent probe solution with a water volume fraction of fw = 98% is 131, 98, 139 and 265 times the corresponding fluorescence intensity value in the fluorescent probe solution containing pure DMSO. Compared with the fluorescent probe solution of pure DMSO solvent (i.e., the volume fraction of water is fw = 0%), the small molecule fluorescent probe with DMSO/H 2 O mixture (the volume fraction of water is fw = 98%) as solvent shows stronger fluorescence intensity and has unique AIE characteristics. The AIE characteristics of H4TCPE, TPE-SA, TPE-SAC and TPE-SDOX solutions were observed by irradiation with 365nm ultraviolet light. As shown in the insets of Figures 6, 8, 10, and 12, in pure DMSO solvent, H4TCPE, TPE-SA, TPE-SAC, and TPE-SDOX have almost no fluorescence visible to the naked eye, but have obvious fluorescence emission when DMSO/H 2 O mixture (the volume fraction of water is fw=98%) is used as solvent. The results show that the small molecule fluorescent probe synthesized by amidation reaction of different sulfonamide groups with TPE maintains the excellent AIE properties of the TPE molecule itself.
不同pH值溶液条件下荧光探针的荧光强度评价Evaluation of fluorescence intensity of fluorescent probes under different pH solution conditions
如图13、16、19、22所示,为不同pH值缓冲液的H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX的荧光光谱,在pH 8.98-1.06范围内,H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX的荧光强度符合Sigmoid Boltzmann函数(如图14、17、20、23)。图13-24中,激发波长为365nm,如图14所示,H4TCPE的pH转变点在pH 4.91附近,超出了生理正常范围(肿瘤微环境pH 6.2-6.9)。As shown in Figures 13, 16, 19, and 22, the fluorescence spectra of H4TCPE, TPE-SA, TPE-SAC, and TPE-SDOX in buffers with different pH values, in the range of pH 8.98-1.06, the fluorescence intensity of H4TCPE, TPE-SA, TPE-SAC, and TPE-SDOX conforms to the Sigmoid Boltzmann function (as shown in Figures 14, 17, 20, and 23). In Figures 13-24, the excitation wavelength is 365nm. As shown in Figure 14, the pH transition point of H4TCPE is around pH 4.91, which is beyond the physiological normal range (tumor microenvironment pH 6.2-6.9).
本方案检测母液配置方法如下:称取10.5mg TPE-SDOX溶于1mL DMSO,配制得6.25mM母液C1;称取5mg TPE-SA溶于0.6183mL DMSO,配制得6.25mM母液C1;称取3mg H4TCPE溶于0.944mL DMSO,配制得6.25mM母液C1。荧光光谱检测方法如下:首先取320uL 6.25mM的对应母液C1溶于1.68mL DMSO,稀释至母液C2浓度为1mM;然后取60uL浓度1mM母液C2,加入至2.94mL不同pH(4.96、5.75、6.27、6.7)的PBS溶液(DMSO/PBS=2/98)。最终浓度为20uM,激发波长为365nm。本方案中,不同pH的PBS缓冲溶液是通过配置0.01M的pH7.2-7.4的标准PBS溶液,加入1M的HCl,调节pH值并通过pH计测得其pH值得到。本方案中,pH为4.96、5.75、6.27、6.7的PBS缓冲液或DMEM溶液配比配制方法如下:向外购的标准PBS溶液/DMEM中,加入不等量的1M的HCl使得溶液调节至达到上述对应的pH值,并通过pH计测得其pH值。The preparation method of the detection mother solution of this scheme is as follows: weigh 10.5mg TPE-SDOX and dissolve it in 1mL DMSO to prepare 6.25mM mother solution C 1 ; weigh 5mg TPE-SA and dissolve it in 0.6183mL DMSO to prepare 6.25mM mother solution C 1 ; weigh 3mg H4TCPE and dissolve it in 0.944mL DMSO to prepare 6.25mM mother solution C 1. The fluorescence spectrum detection method is as follows: first take 320uL of 6.25mM corresponding mother solution C 1 and dissolve it in 1.68mL DMSO, dilute to the concentration of mother solution C 2 is 1mM; then take 60uL of 1mM mother solution C 2 and add it to 2.94mL PBS solution (DMSO/PBS=2/98) with different pH (4.96, 5.75, 6.27, 6.7). The final concentration is 20uM, and the excitation wavelength is 365nm. In this scheme, PBS buffer solutions of different pH are prepared by preparing 0.01M standard PBS solution of pH7.2-7.4, adding 1M HCl, adjusting the pH value and measuring its pH value by a pH meter. In this scheme, the PBS buffer or DMEM solution with a pH of 4.96, 5.75, 6.27, and 6.7 is prepared as follows: add different amounts of 1M HCl to the purchased standard PBS solution/DMEM so that the solution is adjusted to the corresponding pH value, and measure its pH value by a pH meter.
本发明,图14、17、20、23根据如下检测数据绘制,H4TCPE测得不同pH的荧光强度的pH值分别为1.06、1.56、2.06、2.55、3.07、3.5、4.04、4.57、4.96、5.49、6.08、6.52、7.02、7.4、8.0、8.49、8.98。TPE-SA测得不同pH的荧光强度的pH值分别为1.06、2.06、3.07、3.5、4.00、4.57、4.96、5.49、5.78、6.27、6.52、7.02、7.4、8.0、8.49、8.98。TPE-SAC测得不同pH的荧光强度的pH值分别为1.06、2.06、3.07、3.88、4.34、4.96、5.49、5.78、6.08、6.27、6.52、7.4、8.0、8.98。TPE-SDOX测得不同pH的荧光强度的pH值分别为1.06、2.06、3.07、3.43、3.88、4.34、4.77、5.26、5.8、5.95、6.27、6.58、6.77、6.95、7.4、7.6、8.0、8.49、8.98。检测条件为:激发波长:365nm,探针在溶液中的浓度为:20μM。本申请的吸光度检测设备为F96Pro荧光分光光度计(上海棱光技术有限公司)。In the present invention, Figures 14, 17, 20, and 23 are drawn based on the following test data. The pH values of the fluorescence intensity at different pH values measured by H4TCPE are 1.06, 1.56, 2.06, 2.55, 3.07, 3.5, 4.04, 4.57, 4.96, 5.49, 6.08, 6.52, 7.02, 7.4, 8.0, 8.49, and 8.98, respectively. The pH values of the fluorescence intensity at different pH values measured by TPE-SA are 1.06, 2.06, 3.07, 3.5, 4.00, 4.57, 4.96, 5.49, 5.78, 6.27, 6.52, 7.02, 7.4, 8.0, 8.49, and 8.98, respectively. The pH values of the fluorescence intensity at different pH values measured by TPE-SAC were 1.06, 2.06, 3.07, 3.88, 4.34, 4.96, 5.49, 5.78, 6.08, 6.27, 6.52, 7.4, 8.0, and 8.98, respectively. The pH values of the fluorescence intensity at different pH values measured by TPE-SDOX were 1.06, 2.06, 3.07, 3.43, 3.88, 4.34, 4.77, 5.26, 5.8, 5.95, 6.27, 6.58, 6.77, 6.95, 7.4, 7.6, 8.0, 8.49, and 8.98, respectively. The detection conditions were: excitation wavelength: 365 nm, and the concentration of the probe in the solution was: 20 μM. The absorbance detection equipment of the present application was a F96Pro fluorescence spectrophotometer (Shanghai Lingguang Technology Co., Ltd.).
各荧光探针的pH转变点pH transition point of each fluorescent probe
本方案通过磺胺基团进行精确修饰,在分子水平成功地合成了TPE-SA、TPE-SAC和TPE-SDOX化合物。通过检测不同pH溶液中TPE-SA和TPE-SAC的FL,并分析FLmax与小分子荧光探针不同pH之间的关系,实施例8制备的TPE-SA和实施例9制备的TPE-SAC具有明显的pH转折点,分别为5.76±0.02和6.09±0.03。然而,这两种化合物仍未能达到预期的pH变化范围(肿瘤微环境pH 6.2-6.9),因此无法应用于肿瘤微环境检测。相比之下,如图22、23和24所示,实施例4-7所制备的TPE-SDOX对pH显示出较高灵敏的响应,其pH转变点为6.83±0.02。TPE-SDOX表现出明显的AIE特性和灵敏的pH响应,能够应用于靶向肿瘤微环境,达到预期的pH变化范围(pH 6.2-6.9)。H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX的pH响应区分别为4.59-5.24(ΔpHt=0.65)、5.55-5.98(ΔpHt=0.43)、5.78-6.43(ΔpHt=0.65)和6.59-7.08(ΔpHt=0.49)。这些结果表明H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX在较宽的pH范围内都可以实现灵敏的pH检测。This scheme successfully synthesized TPE-SA, TPE-SAC and TPE-SDOX compounds at the molecular level by precise modification of the sulfonamide group. By detecting the FL of TPE-SA and TPE-SAC in different pH solutions and analyzing the relationship between FLmax and different pH of small molecule fluorescent probes, the TPE-SA prepared in Example 8 and the TPE-SAC prepared in Example 9 had obvious pH turning points, which were 5.76±0.02 and 6.09±0.03, respectively. However, these two compounds still failed to reach the expected pH range (tumor microenvironment pH 6.2-6.9), and therefore could not be used for tumor microenvironment detection. In contrast, as shown in Figures 22, 23 and 24, the TPE-SDOX prepared in Examples 4-7 showed a highly sensitive response to pH, with a pH transition point of 6.83±0.02. TPE-SDOX exhibits obvious AIE characteristics and sensitive pH response, and can be used to target tumor microenvironments to achieve the expected pH range (pH 6.2-6.9). The pH response ranges of H4TCPE, TPE-SA, TPE-SAC and TPE-SDOX were 4.59-5.24 (ΔpHt=0.65), 5.55-5.98 (ΔpHt=0.43), 5.78-6.43 (ΔpHt=0.65) and 6.59-7.08 (ΔpHt=0.49), respectively. These results indicate that H4TCPE, TPE-SA, TPE-SAC and TPE-SDOX can achieve sensitive pH detection in a wide pH range.
前述比较例1所得的TPE-STZ,根据上述检测方法测得其pH转变点为6.99±0.03,前述比较例2所得的TPE-SMZ根据上述检测方法测得其pH转变点为7.24±0.03,因此比较例1所得的TPE-STZ和比较例2所得的TPE-SMZ均未达到预期的pH变化范围(pH 6.2-6.9)。The pH transition point of TPE-STZ obtained in the above-mentioned Comparative Example 1 was measured to be 6.99±0.03 according to the above-mentioned detection method, and the pH transition point of TPE-SMZ obtained in the above-mentioned Comparative Example 2 was measured to be 7.24±0.03 according to the above-mentioned detection method. Therefore, both TPE-STZ obtained in Comparative Example 1 and TPE-SMZ obtained in Comparative Example 2 did not reach the expected pH change range (pH 6.2-6.9).
光稳定性评价Photostability evaluation
如图25、26、27、28所示,将H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX母液C2与pH为4.96、5.75、6.27、6.7的PBS缓冲液或DMEM溶液混合配制成含水量98%的溶液。在不同时间点对上述溶液进行荧光强度测定,根据最大荧光发射强度绘制荧光强度与时间的关系图。As shown in Figures 25, 26, 27, and 28, H4TCPE, TPE-SA, TPE-SAC, and TPE-SDOX mother solutions C2 were mixed with PBS buffer or DMEM solution at pH 4.96, 5.75, 6.27, and 6.7 to prepare solutions with a water content of 98%. The fluorescence intensity of the above solutions was measured at different time points, and the relationship between the fluorescence intensity and time was plotted according to the maximum fluorescence emission intensity.
由于光稳定性是评估小分子荧光探针的一个重要参数。通过荧光分光光度计检测H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX在DMEM和PBS溶液中72小时内的FL变化,考察小分子荧光探针的光稳定性。如图所示,根据图25-28所得表征图可知;通过观察到小分子荧光探针在72小时内荧光强度保持稳定,表明其具有良好的荧光稳定性。上述结果表明,TPE荧光探针呈现出良好稳定性。与传统的荧光分子不同,小分子荧光探针在溶液中表现出灵活性,聚集后转变为刚性状态。这种精心设计的构型增强了分子在聚集过程中的稳定性,并且使其能够长时间地保持较高水平的荧光强度。Since photostability is an important parameter for evaluating small molecule fluorescent probes. The FL changes of H4TCPE, TPE-SA, TPE-SAC and TPE-SDOX in DMEM and PBS solutions within 72 hours were detected by fluorescence spectrophotometer to investigate the photostability of small molecule fluorescent probes. As shown in the figure, according to the characterization diagrams obtained in Figures 25-28, it can be seen that the fluorescence intensity of the small molecule fluorescent probe remained stable within 72 hours, indicating that it has good fluorescence stability. The above results show that the TPE fluorescent probe exhibits good stability. Unlike traditional fluorescent molecules, small molecule fluorescent probes show flexibility in solution and transform into a rigid state after aggregation. This carefully designed configuration enhances the stability of the molecule during the aggregation process and enables it to maintain a high level of fluorescence intensity for a long time.
光可逆性评价Photoreversibility evaluation
如图29、30、31、32所示,将H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX母液与不同pH PBS缓冲溶液混合配制含水量98%的溶液,并依次加入0.1M的HCl或NaOH调节小分子荧光探针溶液的pH值,重复5循环,并测得每次pH调整后的小分子荧光探针的荧光强度,根据最大荧光发射强度绘制荧光强度与循环次数的关系图。As shown in Figures 29, 30, 31, and 32, the H4TCPE, TPE-SA, TPE-SAC, and TPE-SDOX stock solutions were mixed with PBS buffer solutions of different pH values to prepare solutions with a water content of 98%, and 0.1 M HCl or NaOH was added in sequence to adjust the pH value of the small molecule fluorescent probe solution. The cycle was repeated for 5 cycles, and the fluorescence intensity of the small molecule fluorescent probe after each pH adjustment was measured. The relationship between the fluorescence intensity and the number of cycles was plotted based on the maximum fluorescence emission intensity.
本方案中,含水量98%的溶液配制方法如下:称取10.5mg TPE-SDOX溶于1mLDMSO,配制得6.25mM母液C1;称取5mg TPE-SA溶于0.751mL DMSO,称取5mg TPE-SAC溶于0.6185mL DMSO,配制得6.25mM母液C1,配制得6.25mM母液C1;称取3mg H4TCPE溶于0.944mLDMSO,配制得6.25mM母液C1;分别取320uL浓度为6.25mM的H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX母液C1溶于1.68mL DMSO,稀释得到浓度为1mM母液C2;取60uL浓度为1mM的上述母液C2加入2.94mL不同pH的PBS溶液(DMSO/PBS=2/98)【含水量98%】,最终浓度达到20uM,激发波长为365nm。In this scheme, the preparation method of the solution with a water content of 98% is as follows: 10.5 mg TPE-SDOX is weighed and dissolved in 1 mL DMSO to prepare a 6.25 mM mother solution C 1 ; 5 mg TPE-SA is weighed and dissolved in 0.751 mL DMSO, 5 mg TPE-SAC is weighed and dissolved in 0.6185 mL DMSO to prepare a 6.25 mM mother solution C 1 ; 3 mg H4TCPE is weighed and dissolved in 0.944 mL DMSO to prepare a 6.25 mM mother solution C 1 ; 320 uL of 6.25 mM H4TCPE, TPE-SA, TPE-SAC and TPE-SDOX mother solutions C 1 are respectively taken and dissolved in 1.68 mL DMSO, and diluted to obtain a 1 mM mother solution C 2 ; 60 uL of the above mother solutions C 1 with a concentration of 1 mM is taken 2 Add 2.94 mL of PBS solution with different pH values (DMSO/PBS=2/98) [water content 98%], the final concentration reaches 20 uM, and the excitation wavelength is 365 nm.
根据如图29、30、31、32分析,得到如下结论:基于光可逆性是评估小分子荧光探针的另一个重要参数,我们通过加入0.1M HCl或NaOH来调节溶液的pH值,研究了H4TCPE、TPE-SA、TPE-SAC和TPE-SDOX对不同pH值下的响应情况。结果显示,在不同pH值下,上述荧光探针均表现出明显的可逆转换过程,并保持有效的荧光响应转化能力。进一步观察发现,即使经过多次循环实验,上述小分子荧光探针仍然能够保持其特殊的可逆性和可重复响应性。无论是在酸性条件还是碱性条件下,它们都展示出稳定而高效地转换成相应荧光信号的能力,这种特殊可逆性和可重复响应性使得上述小分子荧光探针成为理想候选物质,能够在生物医学领域中用于监测和诊断癌症等相关疾病。According to the analysis shown in Figures 29, 30, 31, and 32, the following conclusions were obtained: Based on the fact that photoreversibility is another important parameter for evaluating small molecule fluorescent probes, we adjusted the pH value of the solution by adding 0.1M HCl or NaOH, and studied the response of H4TCPE, TPE-SA, TPE-SAC, and TPE-SDOX to different pH values. The results showed that at different pH values, the above fluorescent probes all exhibited obvious reversible conversion processes and maintained effective fluorescence response conversion capabilities. Further observations showed that even after multiple cycle experiments, the above small molecule fluorescent probes were still able to maintain their special reversibility and repeatable responsiveness. Whether under acidic or alkaline conditions, they exhibit the ability to stably and efficiently convert into corresponding fluorescent signals. This special reversibility and repeatable responsiveness make the above small molecule fluorescent probes ideal candidate substances that can be used in the biomedical field to monitor and diagnose cancer and other related diseases.
以上所述,仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,虽然本发明已以较佳实施例揭露如上,然而并非用以限定本发明,任何熟悉本专业的技术人员,在不脱离本发明技术方案范围内,当可利用上述揭示的技术内容作出些许更动或修饰为等同变化的等效实施例,但凡是未脱离本发明技术方案内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与修饰,均仍属于本发明技术方案的范围内。The above description is only a preferred embodiment of the present invention and does not constitute any form of limitation to the present invention. Although the present invention has been disclosed as a preferred embodiment as above, it is not intended to limit the present invention. Any technician familiar with the profession can make some changes or modifications to equivalent embodiments of equivalent changes using the technical contents disclosed above without departing from the scope of the technical solution of the present invention. However, any simple modification, equivalent change and modification made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention still falls within the scope of the technical solution of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410850451.8A CN118772066A (en) | 2024-06-27 | 2024-06-27 | A slightly acidic environment responsive AIE fluorescent probe and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410850451.8A CN118772066A (en) | 2024-06-27 | 2024-06-27 | A slightly acidic environment responsive AIE fluorescent probe and its preparation method and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118772066A true CN118772066A (en) | 2024-10-15 |
Family
ID=92980176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410850451.8A Pending CN118772066A (en) | 2024-06-27 | 2024-06-27 | A slightly acidic environment responsive AIE fluorescent probe and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118772066A (en) |
-
2024
- 2024-06-27 CN CN202410850451.8A patent/CN118772066A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110283583B (en) | γ-glutamyl transpeptidase responsive molecular probe and its application | |
CN102146284B (en) | A ratiometric fluorescent probe and its application | |
CN103059832B (en) | Near-infrared fluorescent probe compound as well as preparation method and application thereof | |
CN108484622A (en) | The synthesis of multi signal fluorescence probe and its application for distinguishing detection Hcy, Cys and GSH simultaneously | |
CN113461609B (en) | Sulfatase-responsive AIE nano probe and preparation method and application thereof | |
EP3798221A1 (en) | Fluorescent probe and preparation method and use thereof | |
CN108864056B (en) | Near infrared fluorescent compound and its preparation method and application with AIE performance | |
CN105524055A (en) | Preparation and application of fluorescent probe capable of being used for distinguishing cysteine/homocysteine and glutathione | |
Guo et al. | A novel two-channel ratio fluorescent probe for monitoring intracellular pH fluctuations | |
CN115650897B (en) | Fluorescent probe for simultaneously detecting Cys and mitochondrial viscosity and preparation method and application thereof | |
CN113603701A (en) | Colorimetric/fluorescent probe for detecting hypochlorite ions and preparation method and application thereof | |
CN110156688A (en) | A fluorescent probe targeting endoplasmic reticulum to detect polarity and its application | |
CN106432312A (en) | Mitochondria target fluorescence probe, as well as preparation method and application thereof | |
CN109422758B (en) | A near-infrared fluorescence ratio fluorescent probe and its preparation method and application | |
CN114805262A (en) | Viscosity and polarity response type platform fluorescent probe, hydrogen sulfide detection fluorescent probe, synthesis process and application thereof | |
CN109456250A (en) | Hot activation delayed fluorescence (TADF) nano-probe and preparation method thereof and the application in bio-imaging | |
CN115448928B (en) | Semi-cyanine rhodamine fluorescent probe and preparation method and application thereof | |
CN118772066A (en) | A slightly acidic environment responsive AIE fluorescent probe and its preparation method and application | |
CN110437268A (en) | Potassium ion probe and preparation method and application thereof | |
CN113603722B (en) | A kind of polar fluorescent probe and its preparation method and application | |
CN114262333B (en) | Near-infrared fluorescent dye for lysosome super-resolution imaging and preparation method and application thereof | |
CN110229203B (en) | A kind of hexosaminidase fluorescent probe and preparation method and application thereof | |
CN111334080B (en) | Carbonic anhydrase fluorescent probe with high brightness and high light stability | |
CN102633790B (en) | Pyridine rhodamine oxadiazole compound as well as preparation method and application thereof | |
CN113603702A (en) | A colorimetric/fluorescent probe for detecting mercury ions and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |